Showing results (91-100 of 408) with videos related to
Sort By:
Pageof 41
Liver International : Official Journal of the International Association for the Study of the Liver|August 18, 2019
The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosisRafael Paternostro, Katharina Lampichler, Constanze Bardach, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 18, 2017
Transferrin as a predictor of survival in cirrhosisAndré Viveiros, Armin Finkenstedt, Benedikt Schaefer, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|May 11, 2018
Pharmacological decrease of liver stiffness is pressure-related and predicts long-term clinical outcomeFelix Piecha, Mattias Mandorfer, Teresa Peccerella, et al.Platelets|March 16, 2022
Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosisKsenia Brusilovskaya, Benedikt Simbrunner, Silvia Lee, et al.Alimentary Pharmacology & Therapeutics|July 31, 2023
Diabetes impairs the haemodynamic response to non-selective betablockers in compensated cirrhosis and predisposes to hepatic decompensationRafael Paternostro, Mathias Jachs, Lukas Hartl, et al.Journal of Virus Eradication|September 4, 2023
CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centersCaroline Schwarz, Raphael Schubert, Michael Schwarz, et al.Plos One|March 11, 2020
Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opioid substitution in people who inject drugs-First real world data from AustriaCaroline Schmidbauer, Raphael Schubert, Angelika Schütz, et al.Hepatology (Baltimore, Md.)|April 26, 2012
von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosisMonika Ferlitsch, Thomas Reiberger, Matthias Hoke, et al.Plos One|June 4, 2021
Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapyCaroline Schmidbauer, Michael Schwarz, Angelika Schütz, et al.Wiener Klinische Wochenschrift|December 22, 2020
Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherenceLisa Steininger, David Chromy, David Bauer, et al.Pageof 41